| Literature DB >> 22822378 |
Thierry Jauffrais1, Jane Kilcoyne2, Véronique Séchet1, Christine Herrenknecht3, Philippe Truquet1, Fabienne Hervé1, Jean Baptiste Bérard4, Cíara Nulty2, Sarah Taylor1, Urban Tillmann5, Christopher O Miles6, Philipp Hess1.
Abstract
Azaspiracid (AZA) poisoning has been reported following consumption of contaminated shellfish, and is of human health concern. Hence, it is important to have sustainable amounts of the causative toxins available for toxicological studies and for instrument calibration in monitoring programs, without having to rely on natural toxin events. Continuous pilot scale culturing was carried out to evaluate the feasibility of AZA production using Azadinium spinosum cultures. Algae were harvested using tangential flow filtration or continuous centrifugation. AZAs were extracted using solid phase extraction (SPE) procedures, and subsequently purified. When coupling two stirred photobioreactors in series, cell concentrations reached 190,000 and 210,000 cell · mL(-1) at steady state in bioreactors 1 and 2, respectively. The AZA cell quota decreased as the dilution rate increased from 0.15 to 0.3 day(-1), with optimum toxin production at 0.25 day(-1). After optimization, SPE procedures allowed for the recovery of 79 ± 9% of AZAs. The preparative isolation procedure previously developed for shellfish was optimized for algal extracts, such that only four steps were necessary to obtain purified AZA1 and -2. A purification efficiency of more than 70% was achieved, and isolation from 1200 L of culture yielded 9.3 mg of AZA1 and 2.2 mg of AZA2 of >95% purity. This work demonstrated the feasibility of sustainably producing AZA1 and -2 from A. spinosum cultures.Entities:
Keywords: HP-20; LC-MS/MS; azaspiracid; chemostat; dinoflagellate; micro-algae; photobioreactor; solid phase extraction; tangential flow filtration
Mesh:
Substances:
Year: 2012 PMID: 22822378 PMCID: PMC3397445 DOI: 10.3390/md10061360
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 6.085
Figure 1Azaspiracid (AZA) structures and mass-to-charge ratios (m/z) for the molecularions [M + H]+ detected in A. spinosum and in mussels (M. edulis). Toxins found in A. spinosum are shown in bold text.
Figure 2Schematic representation of A. spinosum and AZA production system using photobioreactors in series.
A. spinosum concentration (cell·mL−1), mean estimated spherical diameter (ESD) (µm), cellular volume (µm3·mL−1), toxin content (fg·cell−1), and cell and toxin production (cell·day−1 and µg·day−1, respectively) at the dilution rates studied (0.1, 0.15, 0.2, 0.25, 0.3 day−1) in the two bioreactors in series (R1 and R2). Standard deviations were calculated from sequential repeat measurements of each culture and the last columns present the result of the multifactorial ANOVA followed by a Fisher least-significant-difference test to discriminate differences between values within each factor.
| 0.1 day−1 | 0.15 day−1 | 0.2 day−1 | 0.25 day−1 | 0.3 day−1 | Main factors | Interaction | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R1 | R2 | R1 | R2 | R1 | R2 | R1 | R2 | R1 | R2 | Dilution rate (D) | Reactor (R) | D–R | ||
| Concentration(×103 cell·mL−1) | 9–22 | 174 ± 6 | 164 ± 4 | 193 ± 6 | 214 ± 3 | 194 ± 8 | 214 ± 7 | 190 ± 6 | 221 ± 5 | 187 ± 5 | 220 ± 4 | |||
| 0.1 < 0.15 = 0.2 = 0.25 = 0.3 | R1 < R2 | |||||||||||||
| Mean ESD(µm) | 9–22 | 9.81 ± 0.09 | 10.1 ± 0.1 | 9.59 ± 0.15 | 9.9 ± 0.2 | 9.6 ± 0.2 | 10.1 ± 0.2 | 9.29 ± 0.09 | 9.93 ± 0.04 | 9.5 ± 0.1 | 10.02 ± 0.05 | |||
| 0.25 = 0.3 < 0.15 < 0.2 = 0.1 | R1 < R2 | |||||||||||||
| Cellular volume(×107 µm3·mL−1) | 9–22 | 8.8 ± 0.4 | 8.4 ± 0.3 | 9.2 ± 0.4 | 11.1 ± 0.4 | 9.3 ± 0.6 | 12.0 ± 0.7 | 8.2 ± 0.3 | 11.7 ± 0.2 | 8.5 ± 0.1 | 12.0 ± 0.4 | |||
| 0.1 < 0.25 = 0.3 = 0.15 < 0.2 | R1 < R2 | |||||||||||||
| AZA1 (fg·cell−1) | 3–5 * | 37 ± 5 | 65 ± 8 | 52 ± 6 | 74 ± 4 | 34 ± 12 | 76 ± 14 | 26 ± 2 | 61 ± 3 | 17 ± 1 | 45 ± 3 | |||
| AZA2 (fg·cell−1) | 3–5 * | 10 ± 1 | 16 ± 1 | 15 ± 1 | 24 ± 2 | 10 ± 2 | 19 ± 2 | 12 ± 2 | 25 ± 2 | 7 ± 1 | 18 ± 2 | |||
| AZA1 + 2 (fg·cell−1) | 3–5 * | 47 ± 6 | 81 ± 9 | 67 ± 3 | 98 ± 5 | 44 ± 13 | 95 ± 16 | 38 ± 2 | 86 ± 3 | 24 ± 1 | 63 ± 5 | 0.3 < 0.25 = 0.1< 0.2 < 0.15 | R1 < R2 | |
| Cell production (×109 cell·day−1) | n/a | 1.74 ± 0.06 | 1.64 ± 0.04 | 2.90 ± 0.09 | 3.21 ± 0.05 | 3.9 ± 0.2 | 4.3 ± 0.1 | 4.8 ± 0.2 | 5.5 ± 0.1 | 5.6 ± 0.2 | 6.6 ± 0.1 | Cell production = Cell concentration × D | ||
| Toxin production AZA1 + 2 (µg·day−1) | n/a | 82 ± 3 | 134 ± 15 | 193 ± 9 | 314 ± 15 | 170 ± 50 | 406 ± 64 | 180 ± 10 | 475 ± 17 | 134 ± 5 | 415 ± 33 | Toxin production = Cell production × [AZA1 + 2] | ||
* Each sample was also injected in triplicate to reduce analytical variability; n/a not applicable.
Azaspiracid yield (µg·g−1 ± SD, n = 3) and purity (%) from algal paste after extraction with acetone, ACN or DCM (method 3), and using HP-20 resin.
| Acetone | ACN | DCM | HP-20 | |
|---|---|---|---|---|
| AZA1 + 2 (µg·g−1) | 17.4 ± 0.5 | 18 ± 2 | 17 ± 1 | 17 ± 1 |
| Purity (%) | 0.036 ± 0.002 | 0.07 ± 0.01 | 0.09 ± 0.01 | 0.21 ± 0.03 |
Azaspiracid yield (µg/mL of concentrate or %, ± SD, n = 3) using various HP-20 adsorption and elution procedures (method 4) *.
| Acetone Volume/5 g HP-20 | 3 × 5 mL | 3 × 10 mL | 3 × 25 mL | ||||
|---|---|---|---|---|---|---|---|
| AZA yield (µg/mL) | 1.61 ± 0.07 | 2.1 ± 0.1 | 2.19 ± 0.06 | ||||
|
|
|
|
| ||||
| AZA yield (µg/mL) | 2.6 ± 0.2 | 2.6 ± 0.1 | 2.1 ± 0.2 | ||||
|
|
|
|
|
| |||
| AZA yield (µg/mL) | 0.48 ± 0.06 | 0.52 ± 0.03 | 0.61 ± 0.02 | 0.52 ± 0.08 | |||
| HP-20 adsorption efficiency (% after 24 h of contact with the concentrate) | 93.8 ± 0.1 | ||||||
|
|
|
| |||||
| Time of soaking (a and b), and flow rate (c) |
|
|
| ||||
| Fraction 1 (%) | 77 ± 3 | 74 ± 5 | 98.2 ± 0.5 | ||||
| Fraction 2 (%) | 21 ± 1 | 22 ± 3 | 1.6 ± 0.8 | ||||
| Fraction 3 (%) | 3.0 ± 0.4 | 3.8 ± 0.2 | 0.2 ± 0.1 | ||||
| AZA yield (µg/mL) | 2.43 ± 0.09 | 2.4 ± 0.1 | 2.58 ± 0.01 | ||||
|
|
|
|
| ||||
|
|
|
|
| ||||
* A separate lot of concentrate was used to determine each parameter, so yields are only comparable within each experiment.
AZA mass balance (% ± SD, n = 3 for methods 4 and 6, and n = 7 for methods 3 and 5) obtained after tangential flow filtration using extraction methods 3–6 (indicated in parentheses). Recovery was calculated from the sum of AZA1 + 2 concentration measured in the harvesting tank before tangential flow filtration.
| Method No. | Method description | % Recovery of total |
|---|---|---|
| (3) | Algal paste | 56 ± 9 |
| (4) | Algal retentate + HP-20 | 54 ± 3 |
| (5) | Algal permeate + SPATT | 21 ± 9 |
| (6) | Algal permeate + SPE | 26 ± 4 |
Batch summary table for purification of AZA1 and AZA2.
| Step No. | Step | AZA1 (mg) | AZA2 (mg) | Weight (g) | Purity (%) † |
|---|---|---|---|---|---|
| HP-20 resin extract | 12.5 | 3.2 | 3.04 | 0.5 | |
| 1 | Partitioning | 11.2 | 3.0 | 1.32 | 1.1 |
| 2 | Silica gel | 10.2 | 2.8 | 0.17 | 7.6 |
| 3 | Flash (Phenyl-Hexyl) * | 9.7 | 2.4 | 0.01 | >90 |
| 4 | Prep HPLC (C8/C18) | 9.3 | 2.2 | - | >95 |
| % Recovery (steps 1–4) | 75 | 70 |
* AZA1 and AZA2 were separated from each other in this step. † Total AZA1 + 2, based on w/w.
Figure 3Schematic presentation of the tangential flow filtration for A. spinosum culture.